PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of bmjoBMJ OpenVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
From:
Published online 2012 January 30. doi: 10.1136/bmjopen-2011-000671

Table 2

Median time from marketing authorisation to guidance publication

All drugsCancer drugs
Marketing authorisation to SMC, months (range)7.35 (1–44)8.00 (1–29)
Marketing authorisation to NICE, months (range)21.40 (2–77)23.62 (2–46)
Marketing authorisation to STA, months (range)16.05 (4–41)25.23 (4–41)
Marketing authorisation to MTA, months (range)22.81 (2–77)20.02 (2–46)

MTA, multiple technology assessments; NICE, National Institute of Health and Clinical Excellence; SMC, Scottish Medicines Consortium; STA, single technology assessment.